# Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cisplatin-increases-pd-l1-expression-and-optimizes-immune-check-point-blockade/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ludovic Fournel,Zherui Wu,Nicolas Städler,Diane Damotte,Filippo Lococo,G. Boulle,E. Segal,Antonio Bobbio,Philippe Icard,Jean Trédaniel,Marco Alifano,Patricia Forgez |
| Citations | 261 |
| DOI | 10.1016/j.canlet.2019.08.005 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2967520916 |
| PMID | 31404614 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Jean Trédaniel](https://scholariq.org/researchers/jean-tredaniel/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.